Lupus Science & Medicine®
Lupus Science & Medicine® is a peer-reviewed, open access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases.
It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking lupus studies. Lupus Science & Medicine® (LS&M) is owned by the Lupus Foundation of America and published by BMJ, a respected global provider of evidence-based medical knowledge.
LS&M has received an Impact Factor (IF) of 4.2 - the highest current ranking IF for any lupus-specific journal, ranked 13th out of 58 in rheumatology. The LS&M Scopus CiteScore is now 5.3.
Below, LS&M Co-Editor-in-Chief, Dr. Jill Buyon, discusses what makes this journal so special for lupus researchers and clinicians.
Research on lupus will be considered from fields including, but not limited to, rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry. Submissions from groups of investigators engaged in international collaborations are especially encouraged.
New articles are added year-round so the online content always includes the latest developments in lupus research and treatment.
Articles cover the latest developments from basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases.
Want to know about the hottest topics in lupus research? Check out the list of 'most read articles' on Lupus Science & Medicine®.
Be the first to know. Sign up to receive an eTOC Alerts when a new article is published on Lupus Science & Medicine®.
Authors discuss their research findings and provide additional insight into their conclusions.
Yearly Online Visits
Total Content Views in 2025
Mentions of Journal Content on Social Media & in News Outlets
Out of 58 in Rheumatology Journals
Lupus Science & Medicine® is edited by Jill P. Buyon, Division Director of Rheumatology, Professor of Medicine at New York University School of Medicine; and Ronald F. van Vollenhoven, Professor of Rheumatology and Director of Rheumatology and Immunology Center ARC, Amsterdam UMC, Amsterdam, the Netherlands. The journal has also assembled a world-class team of associate editors and an editorial board to maintain the journal's high standards, high visibility, and credibility.
We are delighted to welcome two distinguished clinician-scientists to the journal as Associate Editors. Professor Martin Aringer, MD, of the University Hospital Carl Gustav Carus and Dresden University of Technology, brings internationally recognized expertise in lupus classification, disease activity, and clinical research. Dr. Keishi Fujio, MD, PhD, of The University of Tokyo Hospital, contributes deep knowledge of immunological mechanisms, translational approaches in autoimmune disease and sophisticated statistical modeling. We are equally pleased to announce four outstanding new members of our Editorial Board: Dr. May Choi (Calgary, Canada), Dr. Paula Ramos (Atlanta, USA), Dr. Warren Raymond (Perth, Australia), and Dr. Edward Vital (Leeds, United Kingdom). Each brings a wealth of expertise spanning clinical trials, genomics, epidemiology, and translational research, further strengthening the journal's global reach and scientific breadth. We warmly welcome all six colleagues and look forward to the valuable contributions they will bring to Lupus Science & Medicine®.